![]() |
16th May 2008 @ 11:24am |
| Subscribe | Instructions To Authors | Advertising/Supplements | Contact Us | Help |
|
Volume 1, Number 2, December 2000New basic science initiatives with the angiotensin II receptor blocker valsartan Angiotensin II (Ang II) plays a key role in the regulation of blood pressure and fluid homeostasis. Valsartan is a highly selective Ang II receptor blocker that specifically and selectively blocks Ang II at the AT1-receptor. In animal models, valsartan has shown positive effects on vasoconstriction, proliferation, remodelling, endothelial function and thrombogenesis, inflammation and atherosclerosis. These data are likely to be confirmed by the results of current clinical trials and valsartan is set to provide improved cardiovascular therapy in the future. JRAAS 2000;1:3-5. View full PDF article (open in new window) Right click on this DOI link and copy link to cite this article (What is a DOI link?) |